BioMarin Pharmaceutical | BMRN - Market Capitalization

Stock Price
57.95
Daily Change
1.41 2.49%
Monthly
-1.56%
Yearly
-7.19%
Q1 Forecast
54.80

BioMarin Pharmaceutical reported $10.78B in Market Capitalization this January of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.6B 10M Sep/2025
Agios Pharmaceuticals USD 2.33B 402M Sep/2025
Alnylam Pharmaceuticals USD 59.77B 17.25B Sep/2025
Amgen USD 151.93B 1.79B Sep/2025
Bayer EUR 27.23B 2.14B Sep/2025
Biogen USD 20.54B 2.13B Sep/2025
BioMarin Pharmaceutical USD 10.4B 142M Sep/2025
Gilead Sciences USD 137.73B 184M Sep/2025
Incyte USD 16.56B 3.38B Sep/2025
Insmed USD 30.44B 11.35B Sep/2025
Ionis Pharmaceuticals USD 10.43B 4.14B Sep/2025
Moderna USD 10.09B 581M Sep/2025
Neurocrine Biosciences USD 13.92B 1.48B Sep/2025
PTC Therapeutics USD 4.88B 1B Sep/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 118.94B 1.6B Feb/2026
Sarepta Therapeutics USD 2.02B 336M Sep/2025
Ultragenyx Pharmaceutical USD 2.9B 539M Sep/2025
United Therapeutics USD 18.96B 6B Sep/2025
Vertex Pharmaceuticals USD 100.41B 13.91B Sep/2025